Dayclazide

In Type II Diabetes & in newly diagnosed NIDDM patients
PrescribeDayclazide M 40/80
“Reduces CVD Risk in Diabetics with Dyslipidaemia.”

Ensure glycaemic control thought 24 hrs without hypoglycemia
Explain the graph

Gliclazide
Restores early peak of insulin secretions
Increases fibrinolytic activity, normalizing prostaglandin metabolism, scavenger free radicals
In Hypoglycemia or variability, Gliclazide is more appropriate to titrate dose.

Metformin
Increases peripheral insulin sensitivity
Does not increase basal or meal induced insulin secretion
Reduces hepatic glucose production

Description

Pioglitazone
Helps cells to become more sensitive to the insulin & controls blood sugar level

“Our Dayclazide range of products available”

Dayclazide M40/80( Gliclazide 40/80mg + Metformin 500) ,
Dayclazide 60MR ( Gliclazide 60 mg XR-Scored tablet ) ,
Dayclazide 80 mg (Gliclazide 80mg – Scored tablet ) ,
Dayclazide XR MEX 60/500 ( Gliclazide 60mg XR + Metformin 500 ) ,
Dayclazide MP 40/80 ( Gliclazide 40/80 mg + metformin 500 + Pioglitazone 15 mg ) ,
Dayclazide Total 30/60( Gliclazide 30/60 mg+ Metformin 500+ Pioglitazone 15 mg ) ,

Thus doctor, to all your patients withType II Diabetes & in newly diagnosed NIDDM
PrescribeDayclazideRange
“Reduces CVD Risk in Diabetics with Dyslipidaemia.”